As psychedelics and AI travel their own development paths, here are some initiatives looking at ways of enhancing the former with the latter's help.

AI-Infused Research Partnerships

The Institute of Biomedical Research Corp. (OTC:MRES) is using AI algorithms, machine learning and predictive models to conduct research on psychedelic compounds, mainly around psilocybin through funding research collaborators at the University of South Africa.

Meanwhile, AI mental health solutions companyCognetivity Neurosciences Ltd.(OTCQB:CGNSF) has struck a deal with the Alzheimer's Society in Oman toward studying cognitive health in patients with dementia and diabetes.

Combining AI and...